Argentina tightens regulation of healthcare products market
This article was originally published in RAJ Devices
Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has launched a programme that aims to tighten its oversight of the entire healthcare products supply chain1,2. It is focused on ensuring improved product traceability and providing better quality and safety guarantees.
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.